Contrast agent-associated nephrotoxicity

Progress in Cardiovascular Diseases

Volumn 45, Issue 6, 2003, Pages 493-503

  Briguori, Carlo ^a,b   Tavano, Davide ^a,b   Colombo, Antonio ^a,b  

^a Department of Cardiology   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; ENDOTHELIN; FENOLDOPAM; GADOLINIUM; NITRIC OXIDE; PROSTAGLANDIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ACUTE KIDNEY FAILURE; ALLERGY; CREATININE BLOOD LEVEL; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HUMAN; HYDRATION; KIDNEY DYSFUNCTION; KIDNEY ISCHEMIA; KIDNEY PERFUSION; KIDNEY TUBULE EPITHELIUM; MORTALITY; NEPHROTOXICITY; OSMOLALITY; OXIDATIVE STRESS; REVIEW; TISSUE INJURY; VERTIGO;

EID: 0037978130     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2003.YPCAD16     Document Type: Review

References (75)

1. Parfrey PS, Griffiths SM, Barrett BJ, et al: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320:143-149, 1989
2. Rudnick MR, Goldfarb S, Wexler L, et al: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. Kidney Int 47:254-26, 1995
3. Davidson CJ, Hlatky M, Morris KG, et al: Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 110:119-124, 1989
4. Schwab SJ, Hlatky MA, Pieper KS, et al: Contrast nephrotoxicity: A randomized controlled trial of a non-ionic and an ionic radiographic contrast agent. N Engl J Med 320:149-153, 1989
5. Cigarroa RG, Lange RA, Williams RH, et al: Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86:649-652, 1989
6. Lautin EM, Freeman NJ, Schoenfeld AH, et al: Radiocontrast-associated renal dysfunction: Incidence and risk factors. AJR Am J Roentgenol 157:49-58, 1991
7. Lautin EM, Freeman NJ, Schoenfeld AH, et al: Radiocontrast-associated renal dysfunction: A comparison of lower-osmolality and conventional high-osmolality contrast media. AJR Am J Roentgenol 157:59-65, 1991
8. Rudnick MR, Berns JS, Cohen RM, et al: Nephrotoxic risks of renal angiography: Contrast-media associated nephrotoxicity and atheroembolism - a critical review. Am J Kidney Dis 24:713-727, 1994
9. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol 5:125-137, 1994
10. Solomon R. Contrast-medium-induced acute renal failure. Kidney Int 53:230-242, 1998
11. Manske CL, Sprafka JM, Strong JH, et al: Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89:615-620, 1990
12. Weinrauch LA, Healy RW, Leland OS, et al: Coronary angiography and acute renal failure in diabetic nephropathy. Ann Intern Med 86:56-59, 1977
13. Barrett BJ, Parfrey PS, Vavasour HM, et al: Contrast nephropathy in patients with impaired renal function: High versus low osmolar media. Kidney Int 41:1274-1279, 1992
14. McCarthy CS, Becker JA. Multiple myeloma and contrast media. Radiology 183:519-521, 1992
15. Holland MD, Galla JH, Sanders PW, et al: Effect of urinary pH and diatrizoate on Bence Jones protein nephrotoxicity in the rat. Kidney Int 27:46-50, 1985
16. McCullough PA, Wolyn R, Rocher LL, et al: Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 103:368-375, 1997
17. Freeman RV, O'Donnell M, Share D, et al: Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90:1068-1073, 2002
18. Briguori C, Manganelli F, Scarpato P, et al: Acetylcysteine and contrast-agent associated nephrotoxicity. J Am Coll Cardiol 40:298-303, 2002
19. Mason RA, Arbeit LA, Giron F: Renal dysfunction after arteriography. JAMA 253:1001-1004, 1985
20. Vliestre RE, Nunn CM, Naverte J, et al: Contrast nephropathy after coronary angioplasty in chronic renal insufficiency. Am Heart J 32:1049-1050, 1996
21. Barrett BJ, Carlisle EJ: Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171-178, 1993
22. Noto TJ, Johnson LE, Krone R, et al: Cardiac catheterization 1990: A report of the registry of the Society for Cardiac Angiography and Interventions. Cathet Cardiovasc Diagn 24:75-83, 1991
23. Davidson CJ, Laskey WK, Hermiller JB, et al: Randomized trial of contrast-media utilization in high-risk PTCA. The COURT trial. Circulation 101:2172-2177, 2000
24. Katzberg RW: Urography into the 21st century: New contrast media, renal handling, imaging characteristics and nephrotoxicity. Radiology 204:297-312, 1997
25. Berg KJ: Nephrotoxicity related to contrast media. Scand J Urol Nephrol 34:317-322, 2000
26. Heyman SN, Reichman J, Brezis M: Pathophysiology of a radiocontrast nephropathy. A role for medullary hypoxia. Invest Radiol 34:685-691, 1999
27. Liss P, Nygren A, Olsson U, et al: Effect of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney. Kidney Int 49:1268-1275, 1996
28. Heyman SN, Brezis M, Epstein FH, et al: Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 49:1268-1275, 1996
29. Berg KJ, Jakobsen JA: Nephrotoxicity related to x-ray contrast media. Adv X-ray Contrast 1:10-18, 1993
30. Porter GA: Radiocontrast-induced nephropathy. Nephrol Dial Transplant 9:146-156, 1994 (suppl 4)
31. Humes HD, Hunt DA, White MD: Direct toxic effect of the radiocontrast agent diatroate on renal proximal tubule cells. Am J Physiol 252:F246-F255, 1987
32. Nordby A, Halgunset J, Haugen OA: Effect of radiographic contrast media on monolayer cell cultures. Invest Radiol 21:234-239, 1986
33. Russo D, Minutolo R, Cianciaruso B, et al: Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 6:1451-1458, 1995
34. Weisberg LS, Kurnik PB, Kurnik BR: Radiocontrast-induced nephropathy in humans. Role of renal vasoconstriction. Kidney Int 41:1408-1415, 1992
35. Caldicott WJ, Hollenberg NK, Abrams HL: Characteristics of response of renal vascular bed to contrast media. Evidence for vasoconstriction induced by renin-angiotensin system. Invest Radiol 5:539-547, 1970
36. Talner LB, Davidson AJ: Renal hemodynamic effects of contrast media. Invest Radiol 3:310-317, 1968
37. Agmon Y, Peleg H, Greenfield Z, et al: Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 94:1069-1075, 1994
38. Cantley LG, Spokes K, Clark B, et al: Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 44:1217-1223, 1993
39. Brooks DP, DePalma PD: Blockade of radiocontrast-induced nephrotoxicity by the endothelin receptor antagonist, SB 209670. Nephron 72:629-636, 1996
40. Erley CM, Duda SH, Rehfuss D, et al: Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration on combination with the adenosine antagonist theophylline. Radiology 14:1146-1149, 1999
41. Katholi RE, Taylor GJ, McCann WP, et al: Nephrotoxicity from contrast media: Attenuation with theophylline. Radiology 195:17-22, 1995
42. Murphy SW, Barrett BJ, Parfrey PS: Contrast nephropathy. J Am Soc Nephrol 11:177-182, 2000
43. Bakris GL, Burnett JC Jr: A role for calcium in radiocontrast induced reduction in renal hemodynamics. Kidney Int 27:465-468, 1995
44. Khoury Z, Schlicht JR, Como J, et al: The effect of prophylactic nifedipine in renal function in patients administer contrast medium. Pharmacotherapy 15: 59-65, 1995
45. Bakris GL, Lass N, Gaber AO, et al: Radiocontrast medium-induced declines in renal function: A role for oxygen free radicals. Am J Physiol 258:F115-F120, 1990
46. Solomon R, Werner C, Mann D, et al: Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416-1420, 1994
47. Barrett BJ, Carlisle EJ: Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171-178, 1993
48. Steinberg EP, Moore RD, Powe NR, et al: Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl J Med 326: 425-430, 1992
49. Tepel M, Van der Giet M, Schwarzfeld C, et al: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184, 2000
50. Tumlip JA, Wang A, Murray PT, et al: Fenodopam mesylate blocks reduction in renal plasma flow after radiocontrast dye infusion: A pilot trial in the prevention of contrast nephropathy. Am Heart J 143:894-903, 2002
51. Osborne E, Sortheland C, Sholl A: Roentgenography of the urinary tract during excretion of sodium iodine. JAMA 80:368-373, 1923
52. Aspelin P, Aubry P, Fransson SG, et al: Nephrotoxicity in high-risk patients. A double-blind randomized multicenter study of iso-osmolar and low-osmolar nonionic contrast media: The nephrotoxicity, high risk, iso-osmolar, contrast media (NEPHRIC) study. N Engl J Med 348:491-499, 2003
53. Mueller C, Buerkle G, Buettner HJ, et al: Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329-336, 2002
54. Taylor AJ, Hotchkiss D, Morse RW, et al: PREPARED: Preparation for Angiography in Renal Dysfunction: A randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 114:1570-1574, 1998
55. Anto HR, Chou SY, Porush JG, et al: Infusion intravenous pyelography and renal function. Effects of hypertonic mannitol in patients with chronic renal insufficiency. Arch Intern Med 141:1652-1656, 1981
56. Stevens MA, McCullough PA, Tobin KJ, et al: A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the PRINCE study. J Am Coll Cardiol 33: 403-411, 1999
57. DiMari J, Megyesi J, Udvarhelyi N, et al: N-acetylcysteine ameliorates ischemic renal failure. Am J Physiol 272:F292-F298, 1997
58. Tariq M, Morais C, Sobki A, et al: N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transplant 14:923-929, 1999
59. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW: Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 89:356-358, 2002
60. Shyu KG, Cheng JJ, Kuan P: Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 40:1383-1388, 2002
61. Allaqaband S, Tumuluri R, Malik AM, et al: Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Cathet Cardiovasc Interv 57: 279-283, 2002
62. Briguori C, Colombo A, Violante A, et al: High versus low dose of acetylcysteine to prevent contrast agents associated nephrotoxicity. J Am Coll Cardiol 41:39A, 2003
63. Pflueger A, Larson TS, Nath KA, et al: Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc 75:1275-1283, 2000
64. Wang A, Holcslaw T, Bashore TM, et al: Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57:1675-1680, 2000
65. Margulies KB, McKinley LJ, Cavero PG, et al: Induction and prevention of radiocontrast-induced nephropathy in dogs with heart failure. Kidney Int 38: 1101-1108, 1990
66. Kurnik BR, Allgren RL, Genter FC, et al: Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 31:674-680, 1998
67. Bakris G, Lass NA, Glock D: Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors. Kidney Int 56:206-210, 1999
68. Kini AS, Mitre CA, Kamran M, et al: Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam. Am J Cardiol 89:999-1002, 2002
69. Vogt B, Ferrari P, Schonholzer C, et al: Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111:692-628, 2001
70. Lehnert T, Keller E, Gondolf K, et al: Effect of hemodialysis after contrast media administration in patients with renal insufficiency. Nephrol Dial Transplant 13:358-362, 1998
71. Tombach B, Bremer C, Reimer P, et al: Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: Results of a randomized study. Radiology 218:651-657, 2001
72. Rieger J, Sitter T, Toepfer M, et al: Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant 17:824-828, 2002
73. Townsend RR, Cohen DL, Katholi R, et al: Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency. Am J Kidney Dis 36: 1207-1212, 2000
74. Hatrick AG, Jarosz JM, Irvine AT: Gadopentate dimeglumine as an alternative contrast agent for use in interventional procedures. Clin Radiol 52:948-952, 1997
75. Hammer FD, Goffette PP, Malaise J, et al: Gadolinium dimeglumine: An alternative contrast agent for digital subtraction angiography. Eur Radiol 9:128-136, 1999